SCHEMBL13537599

SCHEMBL13537599

Cn1cc(CN2CCCCC2)c2ccc(N=O)cc21

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
LMNA P02545 2/20 0.43
GLA P06280 1/20 0.43
HRH3 Q9Y5N1 3/20 0.42
CACNB4 O00305 5/20 0.41
CACNA1A O00555 5/20 0.41
CACNA1G O43497 5/20 0.41
CACNG3 O60359 5/20 0.41
CACNA1F O60840 5/20 0.41
CACNA1H O95180 5/20 0.41
CACNB3 P54284 5/20 0.41
CACNA2D1 P54289 5/20 0.41
CACNG7 P62955 5/20 0.41
CACNA1B Q00975 5/20 0.41
CACNA1D Q01668 5/20 0.41
CACNB1 Q02641 5/20 0.41
CACNG1 Q06432 5/20 0.41
CACNB2 Q08289 5/20 0.41
CACNA1S Q13698 5/20 0.41
CACNA1C Q13936 5/20 0.41
CACNA1E Q15878 5/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13537525 0.90 LMNA (0.46) LMNAGLAHRH3TSHRALDH1A1
SCHEMBL13537351 0.87 HRH3 (0.55) LMNAGLAHRH3KMT2ATSHR
SCHEMBL13537417 0.82 CACNB4 (0.41) CACNB4CACNA1ACACNA1GCACNG3CACNA1F
SCHEMBL3353653 0.80 ACHE (0.50) LMNAGLAHRH3CACNB4CACNA1A
SCHEMBL13537252 0.78 HTR6 (0.44) HRH3GAAKDM4E
SCHEMBL3357630 0.77 ALDH1A1 (0.53) LMNAHRH3CACNB4CACNA1ACACNA1G
SCHEMBL13537395 0.76 HTR6 (0.43) HRH3GAA
SCHEMBL5961922 0.76 LMNA (0.69) LMNAGLATSHRALDH1A1HDAC8
SCHEMBL13537350 0.75 HTR2A (0.41) LMNAALDH1A1HDAC8HDAC6
SCHEMBL13537524 0.72 HRH3 (0.41) HRH3KMT2AALDH1A1GAAKDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2141163-A1 Substituted thiazolidinones, their production and utilisation as medicine Bayer Schering Pharma AG (DE) 2010-01-06 EP disclosed